摘要:
The invention relates to compositions containing at least one superoxide dismutase (SOD) and at least one appropriately selected 5 lipoxygenase (5-LO) inhibitor, and to the uses thereof as medicaments or dietary products for the prevention and/or treatment of allergy-based or non-allergy-based chronic inflammatory diseases.
摘要:
The invention relates to compositions containing at least one superoxide dismutase (SOD) and at least one appropriately selected 5 lipoxygenase (5-LO) inhibitor, and to the uses thereof as medicaments or dietary products for the prevention and/or treatment of allergy-based or non-allergy-based chronic inflammatory diseases.
摘要:
The invention concerns a pharmaceutical composition or a food supplement containing at least an iron complexing protein optionally in the presence of at least an iron salt, and at least a precursor of nitrogen monoxide metabolism and/or at least a chemical donor of nitrogen monoxide, the use of at least an iron complexing agent and of at least a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide, and optionally at least an iron salt for making pharmaceutical compositions in particular for treating asthenia or anaemia or for making a food supplement.
摘要:
The invention concerns a pharmaceutical composition or a food supplement containing at least an iron complexing protein optionally in the presence of at least an iron salt, and at least a precursor of nitrogen monoxide metabolism and/or at least a chemical donor of nitrogen monoxide, the use of at least an iron complexing agent and of at least a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide, and optionally at least an iron salt for making pharmaceutical compositions in particular for treating asthenia or anaemia or for making a food supplement.